CIK 0001818794 · Large accelerated filer
Dyne Therapeutics, Inc.
Sign in to watch- Ticker
- DYN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364883909
- Phone
- (781) 786-8230
- Business address
- 1560 TRAPELO ROAD, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $40,000
- in 1 filing
- Open-market sales, last 90 days
- $247,777
- in 3 filings, $248K under 10b5-1 plans
Net −$207,777. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-09 | Kersten Dirk Director | Sale 10b5-1 | −40,268 | $43.44 | $1.7M | 6,234,119 |
| 2024-08-09 | Kersten Dirk Director | Sale 10b5-1 | −1,160 | $44.04 | $51K | 6,232,959 |
| 2024-08-08 | Kersten Dirk Director | Sale 10b5-1 | −6,377 | $40.74 | $260K | 2,043,623 |
| 2024-08-08 | Kersten Dirk Director | Sale 10b5-1 | −16,357 | $42.97 | $703K | 2,027,266 |
| 2024-08-08 | Kersten Dirk Director | Sale 10b5-1 | −68,936 | $42.87 | $3.0M | 1,958,330 |
| 2024-08-08 | Kersten Dirk Director | Sale 10b5-1 | −6,377 | $40.74 | $260K | 6,410,416 |
| 2024-08-08 | Kersten Dirk Director | Sale 10b5-1 | −16,357 | $42.97 | $703K | 6,394,059 |
| 2024-08-08 | Kersten Dirk Director | Sale 10b5-1 | −68,936 | $42.87 | $3.0M | 6,325,123 |
| 2024-06-24 | HIGH SUSANNA GATTI Chief Operating Officer | Option exercise 10b5-1 | +10,213 | $5.54 | $57K | 159,005 |
| 2024-06-24 | HIGH SUSANNA GATTI Chief Operating Officer | Sale 10b5-1 | −10,213 | $35.33 | $361K | 148,792 |
| 2024-06-24 | HIGH SUSANNA GATTI Chief Operating Officer | Option exercise · Stock option (right to buy) 10b5-1 | −10,213 | 60,486 | ||
| 2024-06-24 | HIGH SUSANNA GATTI Chief Operating Officer | Option exercise 10b5-1 | +10,163 | $5.54 | $56K | 158,955 |
| 2024-06-24 | HIGH SUSANNA GATTI Chief Operating Officer | Sale 10b5-1 | −10,163 | $35.33 | $359K | 148,792 |
| 2024-06-24 | HIGH SUSANNA GATTI Chief Operating Officer | Option exercise · Stock option (right to buy) 10b5-1 | −10,163 | 60,536 | ||
| 2024-06-21 | HIGH SUSANNA GATTI Chief Operating Officer | Option exercise 10b5-1 | +29,787 | $5.54 | $165K | 178,579 |
| 2024-06-21 | HIGH SUSANNA GATTI Chief Operating Officer | Sale 10b5-1 | −29,787 | $35.01 | $1.0M | 148,792 |
| 2024-06-21 | HIGH SUSANNA GATTI Chief Operating Officer | Option exercise · Stock option (right to buy) 10b5-1 | −29,787 | 70,699 | ||
| 2024-06-21 | HIGH SUSANNA GATTI Chief Operating Officer | Option exercise 10b5-1 | +29,787 | $5.54 | $165K | 178,579 |
| 2024-06-21 | HIGH SUSANNA GATTI Chief Operating Officer | Sale 10b5-1 | −29,787 | $35.01 | $1.0M | 148,792 |
| 2024-06-21 | HIGH SUSANNA GATTI Chief Operating Officer | Option exercise · Stock option (right to buy) 10b5-1 | −29,787 | 70,699 |
Page 17 of 29 · 561 trades